Navigation Links
Compound Management and Integrity Goes Online
Date:8/11/2011

LONDON, August 11, 2011 /PRNewswire/ --

Pharma IQ is pioneering new compound management discussion platform with launch of the first ever compound management event - Compound Management and Integrity Online event, which will take an innovative form of 11 online session over the course of 5 weeks, beginning 31st of October 2011.

Simplifying the compound management and integrity process is high on the agenda for many organisations and this was recently recognised by Dr. Mike May in an issue of Drug Discovery and Development, which observed that organisations are seeking more efficient ways of keeping track of libraries of compounds and biological samples as they expand.

12 speakers from 10 countries will deliver 11 presentations:

  • GlaxoSmithKline
  • Leibniz-Insitut für Molekulare Pharmakologie (FMP)
  • AstraZeneca
  • University of Dundee
  • Pfizer Worldwide Research & Development
  • GlaxoSmithKline R&D China
  • Abbott Laboratories
  • Amgen Germany
  • Scripps Florida
  • Actelion Pharmaceuticals Ltd

Key topics to discussed by expert panel include:

  • Reducing facility's footprint for leaner operation
  • Case Study from Astra Zeneca: Linking Automation Systems in the Wake of  Site Closures to Increase Efficiency
  • Compound Management in an Academic Environment - the Dundee Experience
  • Managing the transition and applying the 80/20 rule
  • Overcoming compound management challenges unique to China
  • Case Study from Abbot Laboratories: Addressing the Logistics of Shipping and Receiving Materials Across International Boundaries
  • Compound Management at a small, satellite HTS centre
  • Addressing quality control issues in day-to-day HTS compound management operations
  • Quality assessment and concentration determination of Actelion's compound solutions by automated LCMS and quantitative NMR
  • Successfully collaborating with CROs and external partners

The online form of the event is meant to help to reach the global audience and enable experts from Europe to have a live discussion with their colleagues in US, Canada and Australia without the need to leave their desk.

'In response to the fact that we operate in a time of reduced budgets and time, this conference takes place 100% online, therefore no travelling expenses or timing conflicts would occur,' says Katilen Exum, Compound Management and Integrity Online Director. 'What's more, if someone misses a session, it can always be accesses online as a recorded version of live session. It also means thatnow we can easily access global audience and industry experts from United States will be able to network easily with their colleagues from Europe without the need of leaving their desk or home.'

To find out more about how Compound Management and Integrity Online plans to bring together word-wide renowned experts in the field, or to join the online discussion, visit the event website the website: http://www.compoundmanagementonline.com.  

For more information, images or press passes, contact:

PHARMA IQ
Joanna Checinska, Marketing Manager
Email: joanna.checinska@iqpc.co.uk
Phone: +44(0)2073689300


'/>"/>
SOURCE Pharma IQ
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich Signs Exclusive Agreement With IsoSciences, LLC, to Distribute Isotopically Labeled Bioactive Compounds
2. New USP 797 Regulations May Create New Hazards for Compounding Pharmacy Directors
3. TorreyPines Therapeutics Strategically Repositions as Development Company Focusing on Three Versatile Lead Compounds
4. Retrospective Analysis of Phase 3 Data Suggest Wyeths Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
5. The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
6. Morria Biopharmaceuticals Plc Announces Results From its Pre-Clinical Screening of Novel Anti-Inflammatory Compounds
7. Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
8. Northern Antibiotics Presents New Data on Novel Polymyxin Compounds at the Joint ICAAC/IDSA 2008
9. Baxa Features Rapid-Fill(TM) Colored Labels, PACT(TM) Products, Exacta-Mix(TM) 2400 Compounders and Abacus(TM) Software at the ASHP Mid-Year Clinical Meeting
10. Albemarle Manufactures Zymes PTS, the Lead Compound in a Breakthrough Solubilization Technology
11. ImQuest Presents IND-Enabling Safety Pharmacology and Pharmacokinetic Data for the Therapeutic HIV Compound IQP-0410 at Conference on Retroviruses and Opportunistic Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Jan. 17, 2017   Pulmatrix, Inc . (NASDAQ: ... developing innovative inhaled therapies to address serious pulmonary diseases, ... infections in the lungs of CF patients, PUR1900, has ... by the U.S. Food & Drug Administration. ... to speed the development of novel drugs against important ...
(Date:1/17/2017)... , Jan. 17, 2017 Research ... report "Molecular Diagnostics - Technologies, Markets and Companies" ... ... diagnostics has increased remarkably during the past few years. More ... developing molecular diagnostics and 342 of these are profiled in ...
(Date:1/17/2017)... Jan. 17, 2017  Northwell Health today announced ... of precision cancer research. As ... health care provider, Northwell Health diagnoses and treats ... is a Germany -based oncology ... Together they will greatly expand cancer biobanking activities ...
(Date:1/17/2017)... ... January 17, 2017 , ... Pono Ola , a mind-body wellness firm ... today the official launch of its much-anticipated Pono Board: a re-invented fitness and anti-fatigue ... development for over a year, the patented Pono Board is the world’s only exercise ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/12/2016)... CLEVELAND , Dec. 12, 2016  Researchers ... commercial possibilities for graphene by combining the material ... a highly sensitive pressure detector able to sense ... of a small spider.  The ... and can be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/7/2016)... , Dec. 7, 2016   Avanade ... successful Formula One teams in history, exploit biometric data ... stop performance and maintain the competitive edge against their ... 2016. Avanade has worked with Williams ... range of biometric data (heart rate, breathing rate, temperature ...
Breaking Biology News(10 mins):